Efficacy and Safety of IV Diclofenac (DIC075V) for Pain After Abdominal or Pelvic Surgery

• Status: Completed
• Trial end date: 2007-11-01
• Target enrollment: 0
• Participant gender: All

Summary

This study will compare repeated intermittent IV dosing of diclofenac in patients with moderate to severe post-surgical pain from abdominal or pelvic surgery.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Javelin Pharmaceuticals
• Treatments: Diclofenac; Ketorolac; Ketorolac Tromethamine

Criteria

Inclusion Criteria:

• Scheduled within two weeks of the screening visit to undergo abdominal or pelvic surgery

• Moderate to severe pain within 6 hours following completion of the required surgery.

Exclusion Criteria:

• Surgical procedure involves a subcostal incision.

• Chronic disease or recent cardiovascular events.

• Known allergy or hypersensitivity to the active compounds or any of the excipients used in the study.

Additional Inclusion/Exclusion Criteria May Apply